BCIM
NXTC icon

British Columbia Investment Management’s NextCure NXTC Stock Holding History

British Columbia Investment Management’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-670
Closed -$298K – 825
2020
Q1 		$298K Buy
+670
New +$358K 0.01% 787

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

British Columbia Investment Management's NXTC Position: Q2 2020 in Review

British Columbia Investment Management sold out of NextCure (NXTC) in Q2 2020, closing a stake of 670 shares — an estimated $298K sold.

British Columbia Investment Management first reported a position in NXTC in Q1 2020 and held it in 1 quarter. The position peaked at $298K in Q1 2020. 88 funds tracked by Wall St. Rank hold NXTC as of Q2 2020.

  • British Columbia Investment Management reported no remaining NextCure position as of Q2 2020 after selling out during the quarter.
  • British Columbia Investment Management sold 670 NextCure shares in Q2 2020, an estimated $298K.
  • British Columbia Investment Management first reported a position in NextCure in Q1 2020 and held it in 1 quarter.
  • British Columbia Investment Management's NextCure position peaked at $298K in Q1 2020.
  • 88 funds tracked by Wall St. Rank held NextCure as of Q2 2020.

Based on British Columbia Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.